United States Preventable Vaccines Market Report 2017

October 2017 | 119 pages | ID: UACB4913F69EN
QYResearch

Abstracts

In this report, the United States Preventable Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Preventable Vaccines in these regions, from 2012 to 2022 (forecast).

United States Preventable Vaccines market competition by top manufacturers/players, with Preventable Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• GlaxoSmithKline
• Merck
• Novartis
• Pfizer
• Sanofi
• Takeda Pharmaceutical
• Abbott
• Roche
• AstraZeneca
• Mitsubishi Tanabe Pharma
• Lupin
• Serum Institute of India
• LG Life Sciences
• S K Chemicals
• Shenzhen Kangtai Biological Products
• Sinovac Biotech
• Janssen Pharmaceuticals
• Crucell
• Bavarian Nordic
• Baxter
• Bharat Biotech
• Dynavax
• Valeant Pharmaceuticals
• Protein Sciences
• Panacea Biotec

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Adult Preventable Vaccines
• Pediatric Preventable Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Bacterial Diseases
• Virus Diseases

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Preventable Vaccines Market Report 2017

1 PREVENTABLE VACCINES OVERVIEW

1.1 Product Overview and Scope of Preventable Vaccines
1.2 Classification of Preventable Vaccines by Product Category
  1.2.1 United States Preventable Vaccines Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Preventable Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Adult Preventable Vaccines
  1.2.4 Pediatric Preventable Vaccines
1.3 United States Preventable Vaccines Market by Application/End Users
  1.3.1 United States Preventable Vaccines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Bacterial Diseases
  1.3.3 Virus Diseases
1.4 United States Preventable Vaccines Market by Region
  1.4.1 United States Preventable Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Preventable Vaccines Status and Prospect (2012-2022)
  1.4.3 Southwest Preventable Vaccines Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Preventable Vaccines Status and Prospect (2012-2022)
  1.4.5 New England Preventable Vaccines Status and Prospect (2012-2022)
  1.4.6 The South Preventable Vaccines Status and Prospect (2012-2022)
  1.4.7 The Midwest Preventable Vaccines Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Preventable Vaccines (2012-2022)
  1.5.1 United States Preventable Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 United States Preventable Vaccines Revenue and Growth Rate (2012-2022)

2 UNITED STATES PREVENTABLE VACCINES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Preventable Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Preventable Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Preventable Vaccines Average Price by Players/Suppliers (2012-2017)
2.4 United States Preventable Vaccines Market Competitive Situation and Trends
  2.4.1 United States Preventable Vaccines Market Concentration Rate
  2.4.2 United States Preventable Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Preventable Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PREVENTABLE VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Preventable Vaccines Sales and Market Share by Region (2012-2017)
3.2 United States Preventable Vaccines Revenue and Market Share by Region (2012-2017)
3.3 United States Preventable Vaccines Price by Region (2012-2017)

4 UNITED STATES PREVENTABLE VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Preventable Vaccines Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Preventable Vaccines Revenue and Market Share by Type (2012-2017)
4.3 United States Preventable Vaccines Price by Type (2012-2017)
4.4 United States Preventable Vaccines Sales Growth Rate by Type (2012-2017)

5 UNITED STATES PREVENTABLE VACCINES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Preventable Vaccines Sales and Market Share by Application (2012-2017)
5.2 United States Preventable Vaccines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES PREVENTABLE VACCINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GlaxoSmithKline
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Preventable Vaccines Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GlaxoSmithKline Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Merck
  6.2.2 Preventable Vaccines Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Novartis
  6.3.2 Preventable Vaccines Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Novartis Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer
  6.4.2 Preventable Vaccines Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Sanofi
  6.5.2 Preventable Vaccines Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Sanofi Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Takeda Pharmaceutical
  6.6.2 Preventable Vaccines Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Takeda Pharmaceutical Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Abbott
  6.7.2 Preventable Vaccines Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Abbott Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Roche
  6.8.2 Preventable Vaccines Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Roche Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 AstraZeneca
  6.9.2 Preventable Vaccines Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 AstraZeneca Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Mitsubishi Tanabe Pharma
  6.10.2 Preventable Vaccines Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Mitsubishi Tanabe Pharma Preventable Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Lupin
6.12 Serum Institute of India
6.13 LG Life Sciences
6.14 S K Chemicals
6.15 Shenzhen Kangtai Biological Products
6.16 Sinovac Biotech
6.17 Janssen Pharmaceuticals
6.18 Crucell
6.19 Bavarian Nordic
6.20 Baxter
6.21 Bharat Biotech
6.22 Dynavax
6.23 Valeant Pharmaceuticals
6.24 Protein Sciences
6.25 Panacea Biotec

7 PREVENTABLE VACCINES MANUFACTURING COST ANALYSIS

7.1 Preventable Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Preventable Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Preventable Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Preventable Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PREVENTABLE VACCINES MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Preventable Vaccines Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Preventable Vaccines Sales Volume Forecast by Type (2017-2022)
11.3 United States Preventable Vaccines Sales Volume Forecast by Application (2017-2022)
11.4 United States Preventable Vaccines Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Preventable Vaccines
Figure United States Preventable Vaccines Market Size (K Units) by Type (2012-2022)
Figure United States Preventable Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Adult Preventable Vaccines Product Picture
Figure Pediatric Preventable Vaccines Product Picture
Figure United States Preventable Vaccines Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Preventable Vaccines by Application in 2016
Figure Bacterial Diseases Examples
Table Key Downstream Customer in Bacterial Diseases
Figure Virus Diseases Examples
Table Key Downstream Customer in Virus Diseases
Figure United States Preventable Vaccines Market Size (Million USD) by Region (2012-2022)
Figure The West Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Preventable Vaccines Sales (K Units) and Growth Rate (2012-2022)
Figure United States Preventable Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Preventable Vaccines Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Preventable Vaccines Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Preventable Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Preventable Vaccines Sales Share by Players/Suppliers
Figure 2017 United States Preventable Vaccines Sales Share by Players/Suppliers
Figure United States Preventable Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Preventable Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Preventable Vaccines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Preventable Vaccines Revenue Share by Players/Suppliers
Figure 2017 United States Preventable Vaccines Revenue Share by Players/Suppliers
Table United States Market Preventable Vaccines Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Preventable Vaccines Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Preventable Vaccines Market Share of Top 3 Players/Suppliers
Figure United States Preventable Vaccines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Preventable Vaccines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Preventable Vaccines Product Category
Table United States Preventable Vaccines Sales (K Units) by Region (2012-2017)
Table United States Preventable Vaccines Sales Share by Region (2012-2017)
Figure United States Preventable Vaccines Sales Share by Region (2012-2017)
Figure United States Preventable Vaccines Sales Market Share by Region in 2016
Table United States Preventable Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Preventable Vaccines Revenue Share by Region (2012-2017)
Figure United States Preventable Vaccines Revenue Market Share by Region (2012-2017)
Figure United States Preventable Vaccines Revenue Market Share by Region in 2016
Table United States Preventable Vaccines Price (USD/Unit) by Region (2012-2017)
Table United States Preventable Vaccines Sales (K Units) by Type (2012-2017)
Table United States Preventable Vaccines Sales Share by Type (2012-2017)
Figure United States Preventable Vaccines Sales Share by Type (2012-2017)
Figure United States Preventable Vaccines Sales Market Share by Type in 2016
Table United States Preventable Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Preventable Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Preventable Vaccines by Type (2012-2017)
Figure Revenue Market Share of Preventable Vaccines by Type in 2016
Table United States Preventable Vaccines Price (USD/Unit) by Types (2012-2017)
Figure United States Preventable Vaccines Sales Growth Rate by Type (2012-2017)
Table United States Preventable Vaccines Sales (K Units) by Application (2012-2017)
Table United States Preventable Vaccines Sales Market Share by Application (2012-2017)
Figure United States Preventable Vaccines Sales Market Share by Application (2012-2017)
Figure United States Preventable Vaccines Sales Market Share by Application in 2016
Table United States Preventable Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States Preventable Vaccines Sales Growth Rate by Application (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Preventable Vaccines Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Preventable Vaccines Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Preventable Vaccines Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Preventable Vaccines Sales Growth Rate (2012-2017)
Figure Merck Preventable Vaccines Sales Market Share in United States (2012-2017)
Figure Merck Preventable Vaccines Revenue Market Share in United States (2012-2017)
Table Novartis Basic Information List
Table Novartis Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Preventable Vaccines Sales Growth Rate (2012-2017)
Figure Novartis Preventable Vaccines Sales Market Share in United States (2012-2017)
Figure Novartis Preventable Vaccines Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Preventable Vaccines Sales Growth Rate (2012-2017)
Figure Pfizer Preventable Vaccines Sales Market Share in United States (2012-2017)
Figure Pfizer Preventable Vaccines Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Preventable Vaccines Sales Growth Rate (2012-2017)
Figure Sanofi Preventable Vaccines Sales Market Share in United States (2012-2017)
Figure Sanofi Preventable Vaccines Revenue Market Share in United States (2012-2017)
Table Takeda Pharmaceutical Basic Information List
Table Takeda Pharmaceutical Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takeda Pharmaceutical Preventable Vaccines Sales Growth Rate (2012-2017)
Figure Takeda Pharmaceutical Preventable Vaccines Sales Market Share in United States (2012-2017)
Figure Takeda Pharmaceutical Preventable Vaccines Revenue Market Share in United States (2012-2017)
Table Abbott Basic Information List
Table Abbott Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Preventable Vaccines Sales Growth Rate (2012-2017)
Figure Abbott Preventable Vaccines Sales Market Share in United States (2012-2017)
Figure Abbott Preventable Vaccines Revenue Market Share in United States (2012-2017)
Table Roche Basic Information List
Table Roche Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Preventable Vaccines Sales Growth Rate (2012-2017)
Figure Roche Preventable Vaccines Sales Market Share in United States (2012-2017)
Figure Roche Preventable Vaccines Revenue Market Share in United States (2012-2017)
Table AstraZeneca Basic Information List
Table AstraZeneca Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AstraZeneca Preventable Vaccines Sales Growth Rate (2012-2017)
Figure AstraZeneca Preventable Vaccines Sales Market Share in United States (2012-2017)
Figure AstraZeneca Preventable Vaccines Revenue Market Share in United States (2012-2017)
Table Mitsubishi Tanabe Pharma Basic Information List
Table Mitsubishi Tanabe Pharma Preventable Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mitsubishi Tanabe Pharma Preventable Vaccines Sales Growth Rate (2012-2017)
Figure Mitsubishi Tanabe Pharma Preventable Vaccines Sales Market Share in United States (2012-2017)
Figure Mitsubishi Tanabe Pharma Preventable Vaccines Revenue Market Share in United States (2012-2017)
Table Lupin Basic Information List
Table Serum Institute of India Basic Information List
Table LG Life Sciences Basic Information List
Table S K Chemicals Basic Information List
Table Shenzhen Kangtai Biological Products Basic Information List
Table Sinovac Biotech Basic Information List
Table Janssen Pharmaceuticals Basic Information List
Table Crucell Basic Information List
Table Bavarian Nordic Basic Information List
Table Baxter Basic Information List
Table Bharat Biotech Basic Information List
Table Dynavax Basic Information List
Table Valeant Pharmaceuticals Basic Information List
Table Protein Sciences Basic Information List
Table Panacea Biotec Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Preventable Vaccines
Figure Manufacturing Process Analysis of Preventable Vaccines
Figure Preventable Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Preventable Vaccines Major Players/Suppliers in 2016
Table Major Buyers of Preventable Vaccines
Table Distributors/Traders List
Figure United States Preventable Vaccines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Preventable Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Preventable Vaccines Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Preventable Vaccines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Preventable Vaccines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Preventable Vaccines Sales Volume (K Units) Forecast by Type in 2022
Table United States Preventable Vaccines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Preventable Vaccines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Preventable Vaccines Sales Volume (K Units) Forecast by Application in 2022
Table United States Preventable Vaccines Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Preventable Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Preventable Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Preventable Vaccines Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources